Saurabh MishraManaging Partner

saurabhSaurabh, Founder and Managing Partner has been instrumental in valuing young life sciences companies with innovative products. His areas of expertise include valuation of R&D Projects, corporate finance analysis, and go-to- market strategy. He has successfully valued and helped life sciences entrepreneurs understand the value of their technology and prepared them to negotiate with licensee or the investors.

His rich international experience includes engagements across US, India, Brazil, Colombia, Egypt and Nigeria. He has been chosen as an expert by European Commission for evaluating Horizon2020 projects, EU’s biggest programme ever in the field of research and innovation.

Saurabh received his engineering degree from BIT Sindri, India and earned an MBA from ESADE Business School in Barcelona where he gained various leadership positions in the campus such as President of ESADE Entrepreneurship Club. In addition, Saurabh teaches Corporate Finance and Valuation at La Salle (Universitat Ramon Llull). Saurabh is a CFA Level III Candidate 2017.

Saurabh was born in India and has worked in India, the USA and in Spain.



Ramon FernandezPartner, Spain

RamonRamon is a scientist cum entrepreneur who brings to Farmantra, 28 years of valuable experience in biopharmaceutical industry. He started his own venture in Diagnostics in 1984 and sold his company to Leti Laboratories in 2008. He was awarded by Barcelona Activa for his contribution to the development of synergies between the Industry and University in 2006. He was also a member of Spanish steering committee of Health Ministry for Toxic Oil Syndrome in 1985.

Besides his technical skills, he developed his sales and marketing acumen by working as Sales and Marketing manager in different biopharmaceutical companies.

Ramon is a PhD in Biochemistry and Molecular Biology from Universidad Autonoma de Madrid.



Dr. Animesh Poddar Partner, USA

Ramon Dr. Animesh Poddar is our strategic Partner in USA. He brings along more than 17 years of pharmaceutical experience with Roche, GSK and Astrazeneca in different positions such as Licensing and Business Development, Sales operations and marketing strategy.

While working with the strategic partnering group within AstraZeneca, Dr. Poddar played a key role in signing several deals worth more than $3.5B in total – e.g. acquisition of Ardea BioSciences and Omthera Pharmaceuticals; out-licensing of Nexium OTC to Pfizer (global) and Forxiga to Ono (Japan); in-licensing of WEE1 inhibitor from Merck, and Fentanyl nasal spray from Archimedes (Australia); a multi-asset co-development and co-promotion deal with Amgen; several early stage assets and platforms.

Dr. Poddar received his BS in Pharmacy from Jadavpur University, PhD in Pharmacology from the University of Georgia (USA) and MBA degree from Bowling Green State University (USA).



Our team speaks English, French, Spanish, Catalan and Hindi.